Literature DB >> 4044579

Alu RNA-protein complexes formed in vitro react with a novel lupus autoantibody.

R Kole, L D Fresco, J D Keene, P L Cohen, R A Eisenberg, P G Andrews.   

Abstract

We have screened sera from patients with systemic lupus erythematosus for reactivity with RNA transcribed in vitro using HeLa whole cell extracts. Sera from 14 out of 114 patients precipitated an RNA transcribed by RNA polymerase III from a plasmid containing an Alu family sequence (i.e. the repetitive DNA sequence that is cut by the Alu restriction enzyme) located upstream from the human gamma G-globin gene. These Alu transcripts were not precipitated by anti-La, anti-Sm, anti-RNP or anti-Ro antibodies, suggesting that Alu RNA was precipitated by a previously undescribed lupus specificity. Analysis of [35S]methionine-labeled immunoprecipitates indicated that Alu RNA binds a protein of about 68 kDa. This protein may be Alu specific since three different Alu transcripts were precipitated by the anti-Alu sera whereas another RNA polymerase III transcript, adenovirus VA I RNA, was not precipitated by the same sera.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044579

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function.

Authors:  R J Maraia; R V Intine
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Autoimmune diseases and polyamines.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

3.  Human autoantibodies reactive with the signal-recognition particle.

Authors:  W H Reeves; S K Nigam; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

Authors:  L A Casciola-Rosen; G Anhalt; A Rosen
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.